Type
. Immunohistologic alteration of skin and ultrastructural changes of glomerular basement membranes in leprosy. The American journal of tropical medicine and hygiene. 1974;23(1):81-6.
Type
. Quantitative evaluation of the progress of intracellular infection in vitro: incorporation of 3H-thymidine into deoxyribonucleic acid by Mycobacterium leprae in cultivated blood monocytes. Infection and immunity [Internet]. 1974;9(1):187-91. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC414783/pdf/iai00241-0199.pdf
Type
. Letter: Sensory loss in leprosy. Lancet (London, England). 1973;2(7844):1493-4.
Type
. Immunologic studies on leprosy. 2. Antigenic studies of Mycobacterium leprae. Zeitschrift fur Tropenmedizin und Parasitologie. 1973;24:Suppl 1:66-72.
Type
. Letter: Thalidomide in erythema nodosum leprosum. Lancet (London, England). 1973;2(7839):1201-2.
Type
. Leprosy-susceptibility testing of armadillos. 2. Late cell and bacterial responses at inoculation site of living leprosy bacilli in 'resistant' armadillos. Microbios. 1973;8(31):241-6.
Type
. The pathogenesis of the early skin lesion in leprosy. The Journal of pathology. 1973;111(3):191-206.
Type
. Letter: Thalidomide in erythema nodosum leprosum. Lancet (London, England). 1973;2(7835):966.
Type
. Treatment of erythema nodosum leprosum with thalidomide. Lancet (London, England). 1973;2(7828):567-8.
Type
. The variants of the group-specific component. A review of their distribution in human populations. Israel journal of medical sciences. 1973;9(9):1133-46.